Pharmacolog Inc. has received an order for 2 WasteLog® systems from Southern Illinois Healthcare Systems Carbondale, Illinois. The systems will be used to control the return of narcotics at two of Southern Illinois Healthcare’s hospitals.
Southern Illinois Healthcare Systems (SIH), Illinois, US is a healthcare organization with 3,400 employees that currently consists of over thirty facilities, including three inpatient hospitals, three clinics and numerous physician offices. After evaluation, SIH decided to replace its current system for control of returned narcotic drugs in favor of Pharmacolog and WasteLog® and acquires two WasteLog® systems. The use of WasteLog® is part of SIH’s Drug Diversion Prevention program. The deal is a direct sale via Pharmacolog USA Inc. and is estimated to generate revenue of the equivalent of SEK 650,000 over three years.
CEO, Mats Högberg comments: “We are extremely happy that SIH chooses to replace its current solution with WasteLog. It is a huge message of strength for WasteLog® and proof that our solution is competitive and technically superior to other systems on the market. Jeff has also done a fantastic job of closing this order, despite the very difficult conditions that prevailed during the pandemic.”
Sales Director US, Jeffrey Marton comments: “Working with Southern Illinois Healthcare has been a great experience. After many discussions with their Drug Diversion Specialist and demos it was clear that they wanted, and needed, a change from their current system. Southern Illinois Healthcare was very impressed with the WasteLog® accuracy and technology. However, what really sealed the deal was that the WasteLog system is going to save them time and is more cost effective. This is another excellent win for Pharmacolog. Knowing that we beat our competition again is phenomenal especially in the middle of this pandemic. I would like to thank the Pharmacolog team in Uppsala for their constant efforts with every customer as we continue to grow the North American Market.”
This information is insider information that Pharmacolog AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication through the agency of the contact person set out above, on February 2, 2021 at 09:30.
About Pharmacolog AB
Pharmacolog is specialized in developing systems and solutions for more effective and safer use of intravenous drugs. The company’s first product, DrugLog®, enables a nurse or pharmacist to quickly and easily verify that an injectable drug has the right identity and concentration. Pharmacolog’s long-term vision is an individually optimized medication for each individual patient, considering all available parameters in the control and distribution of the drug. Further information regarding the company is available at http://www.pharmacolog.com. The company’s Certified Adviser is Mangold Fondkommission AB, which can be reached on telephone number +46 8-5030 15 50 or through CA@mangold.se.